This is a preview of subscription content, log in via an institution to check access.
References
Bowen JD, Petersdorf SH, Richards TL, et al. Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis. Clin Pharmacol Ther 1998 Sep; 64: 339–46
ICOS’s LeukArrest disappoints in MS. Marketletter 1998 Sep 28; 25: 20
ICOS announces phase 2 clinical trial in myocardial infarction. Business Wire [online]. Available from: URL: http://www. newspage.com. [Accessed 1998 Feb 13]
Rights and permissions
About this article
Cite this article
Hu23F2G. Drugs R&D 1, 25–26 (1999). https://doi.org/10.2165/00126839-199901010-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00126839-199901010-00009